 |
|
Prevalence of HTLV-III/LAV in Household Contacts of Patients With Confirmed AIDS and Controls in Kinshasa, Zaire
Jonathan M. Mann, MD, MPH;
Thomas C. Quinn, MD;
Henry Francis, MD;
Nzila Nzilambi, MD;
Ngaly Bosenge, MD;
Kapita Bila, MD;
Joseph B. McCormick, MD;
Kalisa Ruti, MD;
Pangu Kaza Asila, MD, MPH;
James W. Curran, MD, MPH
JAMA. 1986;256(6):721-724.
Abstract
| |
Household members of 46 patients with confirmed acquired immunodeficiency syndrome (AIDS) and 43 human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV)-seronegative controls from Kinshasa, Zaire, were identified and sought for serologic testing for evidence of HTLV-III/LAV infection. Twenty (9.8%) of 204 case-household members and three (1.9%) of 155 control-household members were HTLV-III/LAV seropositive (relative risk=5.1; 95% confidence interval, 1.7 to 15.2). Eleven (61.1%) of 18 spouses of patients with AIDS were HTLV-III/LAV seropositive, compared with one (3.7%) of 27 control spouses (relative risk=16.5; 95% confidence interval, 3.7 to 75.0). Except for spouses, the rate of HTLV-III/LAV seropositivity did not differ significantly between case and control households. Furthermore, for adults in case households who were not spouses, the number seropositive for HTLV-III/LAV was identical to that predicted from sex- and age-specific HTLV-III/LAV seroprevalence rates. These data from Zaire confirm the results of US and European studies of household contacts of infected hemophiliacs and pediatric patients with AIDS.
(JAMA 1986;256:721-724)
Author Affiliations
From the Project SIDA (Drs Mann, Francis, Nzilambi, and Bosenge), the Ministry of Health (Drs Ruti and Asila), and the Mama Yemo Hospital (Dr Bila), Kinshasa, Zaire, the AIDS Program (Drs Mann and Curran) and the Special Pathogens Branch Division of Viral Diseases (Dr McCormick), Center for Infectious Diseases Centers tor Disease Control, Atlanta; and the Laboratory of Immu noregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md (Drs Quinn and Francis)
Footnotes
Use of trade names is for identification only and does not constitute endorsement by the US Department of Health and Human Services or any of its agencies.
Reprint requests to Centers for Disease Control, Bldg 6, Room 292, Atlanta, GA 30333 (Dr Curran)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Case series and exposure series: the role of studies without controls in providing information about the etiology of injury or disease
Cummings and Weiss
Inj. Prev. 1998;4:54-57.
ABSTRACT
| FULL TEXT
Aggregation of Human Immunodeficiency Virus Type 1 by Human Salivary Secretions
Bergey et al.
CROBM 1993;4:467-474.
ABSTRACT
| FULL TEXT
Human Immunodeficiency Virus Infection Among Peace Corps Volunteers in Zaire: No Evidence for Unusual Modes of Transmission
Cappello et al.
Arch Intern Med 1991;151:1328-1330.
ABSTRACT
The Epidemiology of Acquired Immunodeficiency Syndrome Among Heterosexuals
Haverkos and Edelman
JAMA 1988;260:1922-1929.
ABSTRACT
Investigations of AIDS Patients With No Previously Identified Risk Factors
Castro et al.
JAMA 1988;259:1338-1342.
ABSTRACT
Do Alternate Modes for Transmission of Human Immunodeficiency Virus Exist? A Review
Lifson
JAMA 1988;259:1353-1356.
ABSTRACT
Risk of Human Immunodeficiency Virus Transmission From Heterosexual Adults With Transfusion-Associated Infections
Peterman et al.
JAMA 1988;259:55-58.
ABSTRACT
Human Immunodeficiency Virus Infection and the Acquired Immune Deficiency Syndrome: A Review
Schechter and Coates
Sex Abuse 1988;1:205-225.
ABSTRACT
Chronic Vaginal Candidiasis in Women With Human Immunodeficiency Virus Infection
Rhoads et al.
JAMA 1987;257:3105-3107.
ABSTRACT
Zaire: Nonsexual Household Transmission of AIDS
Rothman
JAMA 1986;256:3091-3091.
ABSTRACT
Worldwide Strategies for HIV Control: WHO'S Special Programme on AIDS
Mann
J Law Med Ethics 1986;14:290-297.
|
